Skip to the page

Data / Form D filings / Augmedix, Inc.

Augmedix, Inc.: Form D filings

Augmedix, Inc., a health care company in San Francisco, CA, filed 3 Form D notices with the SEC between 2020 and 2023. The latest, on May 3, 2023, reports $12 million sold of a $12 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
111 SUTTER STREET, SUITE 1300, San Francisco, CA, 94104
Phone
(888) 669-4885
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1769804

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 3, 2023New notice$11,999,999$11,999,9992Apr 19, 2023sec.gov
Oct 19, 2020New notice$29,942,924$29,942,92461Oct 5, 2020sec.gov
Oct 19, 2020New notice$25,910,803$25,910,80336Oct 5, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Laurie A. S. McGrawDirector
Ian A. S. ShakilDirector
Joseph A. S. MarksDirector
William J. FebboDirector
Jason A. S. KrikorianDirector
Margie A. S. TraylorDirector
Robert J. FaulknerDirector
Roderick J. O'ReillyDirector
Emmanuel KrakarisExecutive Officer, Director

Other health care companies in California that filed recently

Every Form D from the week of May 1, 2023 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Augmedix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.